232 related articles for article (PubMed ID: 18329002)
21. Preparation and in vitro evaluation of radioiodinated bakuchiol as an anti tumor agent.
Bapat K; Chintalwar GJ; Pandey U; Thakur VS; Sarma HD; Samuel G; Pillai MR; Chattopadhyay S; Venkatesh M
Appl Radiat Isot; 2005 Mar; 62(3):389-93. PubMed ID: 15607914
[TBL] [Abstract][Full Text] [Related]
22. Assessment of monoamine transporter inhibition in the mediation of cocaine-induced conditioned taste aversion.
Freeman KB; Rice KC; Riley AL
Pharmacol Biochem Behav; 2005 Nov; 82(3):583-9. PubMed ID: 16337262
[TBL] [Abstract][Full Text] [Related]
23. Monoamine transporter as a target molecule for psychostimulants.
Sora I; Li B; Fumushima S; Fukui A; Arime Y; Kasahara Y; Tomita H; Ikeda K
Int Rev Neurobiol; 2009; 85():29-33. PubMed ID: 19607959
[TBL] [Abstract][Full Text] [Related]
24. The metabotropic glutamate receptor 7 allosteric modulator AMN082: a monoaminergic agent in disguise?
Sukoff Rizzo SJ; Leonard SK; Gilbert A; Dollings P; Smith DL; Zhang MY; Di L; Platt BJ; Neal S; Dwyer JM; Bender CN; Zhang J; Lock T; Kowal D; Kramer A; Randall A; Huselton C; Vishwanathan K; Tse SY; Butera J; Ring RH; Rosenzweig-Lipson S; Hughes ZA; Dunlop J
J Pharmacol Exp Ther; 2011 Jul; 338(1):345-52. PubMed ID: 21508084
[TBL] [Abstract][Full Text] [Related]
25. Attenuation of the norepinephrine transporter activity and trafficking via interactions with alpha-synuclein.
Wersinger C; Jeannotte A; Sidhu A
Eur J Neurosci; 2006 Dec; 24(11):3141-52. PubMed ID: 17156375
[TBL] [Abstract][Full Text] [Related]
26. The new psychoactive substances 5-(2-aminopropyl)indole (5-IT) and 6-(2-aminopropyl)indole (6-IT) interact with monoamine transporters in brain tissue.
Marusich JA; Antonazzo KR; Blough BE; Brandt SD; Kavanagh PV; Partilla JS; Baumann MH
Neuropharmacology; 2016 Feb; 101():68-75. PubMed ID: 26362361
[TBL] [Abstract][Full Text] [Related]
27. Monoamine transporters: from genes to behavior.
Gainetdinov RR; Caron MG
Annu Rev Pharmacol Toxicol; 2003; 43():261-84. PubMed ID: 12359863
[TBL] [Abstract][Full Text] [Related]
28. Ex vivo assessment of binding site occupancy of monoamine reuptake inhibitors: methodology and biological significance.
Lengyel K; Pieschl R; Strong T; Molski T; Mattson G; Lodge NJ; Li YW
Neuropharmacology; 2008 Jul; 55(1):63-70. PubMed ID: 18538356
[TBL] [Abstract][Full Text] [Related]
29. N-Alkylated Analogs of 4-Methylamphetamine (4-MA) Differentially Affect Monoamine Transporters and Abuse Liability.
Solis E; Partilla JS; Sakloth F; Ruchala I; Schwienteck KL; De Felice LJ; Eltit JM; Glennon RA; Negus SS; Baumann MH
Neuropsychopharmacology; 2017 Sep; 42(10):1950-1961. PubMed ID: 28530234
[TBL] [Abstract][Full Text] [Related]
30. Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3.
Duan H; Wang J
J Pharmacol Exp Ther; 2010 Dec; 335(3):743-53. PubMed ID: 20858707
[TBL] [Abstract][Full Text] [Related]
31. Cynomorium songaricum extracts functionally modulate transporters of gamma-aminobutyric acid and monoamine.
Zhao G; Wang J; Qin GW; Guo LH
Neurochem Res; 2010 Apr; 35(4):666-76. PubMed ID: 20084455
[TBL] [Abstract][Full Text] [Related]
32. Insulin modulates cocaine-sensitive monoamine transporter function and impulsive behavior.
Schoffelmeer AN; Drukarch B; De Vries TJ; Hogenboom F; Schetters D; Pattij T
J Neurosci; 2011 Jan; 31(4):1284-91. PubMed ID: 21273413
[TBL] [Abstract][Full Text] [Related]
33. MPTP-induced neuroblast apoptosis in the subventricular zone is not regulated by dopamine or other monoamine transporters.
Shibui Y; He XJ; Uchida K; Nakayama H
Neurotoxicology; 2009 Nov; 30(6):1036-44. PubMed ID: 19616025
[TBL] [Abstract][Full Text] [Related]
34. Effects of N-Alkyl-4-Methylamphetamine Optical Isomers on Plasma Membrane Monoamine Transporters and Abuse-Related Behavior.
Battisti UM; Sitta R; Harris A; Sakloth F; Walther D; Ruchala I; Negus SS; Baumann MH; Glennon RA; Eltit JM
ACS Chem Neurosci; 2018 Jul; 9(7):1829-1839. PubMed ID: 29697951
[TBL] [Abstract][Full Text] [Related]
35. Stimulant and reinforcing effects of cocaine in monoamine transporter knockout mice.
Rocha BA
Eur J Pharmacol; 2003 Oct; 479(1-3):107-15. PubMed ID: 14612142
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and monoamine transporter affinity of 3'-analogs of 2-beta-carbomethoxy-3-beta-(4'-iodophenyl)tropane (beta-CIT).
Bois F; Baldwin RM; Kula NS; Baldessarini RJ; Innis RB; Tamagnan G
Bioorg Med Chem Lett; 2004 May; 14(9):2117-20. PubMed ID: 15080991
[TBL] [Abstract][Full Text] [Related]
37. In vivo characterization of a novel phenylisothiocyanate tropane analog at monoamine transporters in rat brain.
Murthy V; Martin TJ; Kim S; Davies HM; Childers SR
J Pharmacol Exp Ther; 2008 Aug; 326(2):587-95. PubMed ID: 18492949
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and monoamine transporter affinity of 2beta-carbomethoxy-3beta-(4'-p-substituted phenyl)-piperidine analogs of cocaine.
Bois F; Baldwin RM; Kula NS; Baldessarini RJ; Al Tikriti M; Innis RB; Tamagnan GD
Bioorg Med Chem Lett; 2006 Oct; 16(19):5222-5. PubMed ID: 16908151
[TBL] [Abstract][Full Text] [Related]
39. Distribution of organic cation transporter 3, a corticosterone-sensitive monoamine transporter, in the rat brain.
Gasser PJ; Orchinik M; Raju I; Lowry CA
J Comp Neurol; 2009 Feb; 512(4):529-55. PubMed ID: 19025979
[TBL] [Abstract][Full Text] [Related]
40. Defining the dopamine transporter proteome by convergent biochemical and in silico analyses.
Maiya R; Ponomarev I; Linse KD; Harris RA; Mayfield RD
Genes Brain Behav; 2007 Feb; 6(1):97-106. PubMed ID: 16643512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
